Réactualisation de la méthode française d’imputabilité des effets indésirables des médicaments
Therapie, 66 6 (2011) 517-525
Published online: 2011-12-21
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Respiratory Disorders Associated with Antibody–Drug Conjugates: A Combined Analysis of the French and the WHO Pharmacovigilance Databases
Victor Mirleau, Alex Hlavaty, Etienne‐Marie Jutant, Florence Hennegrave, Kévin Bihan, Romane Freppel, Clément Cholle, Delphine Bourneau‐Martin, Claire Lafay‐Chebassier, Julien Mahé, Matthieu Bainaud and Marion AlloucheryClinical Pharmacology & Therapeutics 119 (3) 660 (2026)
https://doi.org/10.1002/cpt.70119
Unveiling the Limits of Anticholinergic Burden Scales: A Study of Adverse Drug Reactions in the French Pharmacovigilance Database
Pauline-Eva Pecquet, Julien Moragny, Valérie Gras, Pauline Schiro, Sylvine Pinel, Solène M. Laville and Sophie LiabeufDrug Safety 49 (5) 591 (2026)
https://doi.org/10.1007/s40264-025-01643-5
Recognizing Arthralgia as a Potential Adverse Effect of CFTR Modulators: A Case Report
Flora Charbonneau, Magali Dupuy-Grasset, Jeanne Languepin and Marie-Laure LarocheClinical Therapeutics 48 (1) 117 (2026)
https://doi.org/10.1016/j.clinthera.2025.11.007
COVID-19 infection and risk of adverse drug reactions: Cohort study
Paul-Benoît Fargier, Marlène Damin-Pernik, Manon Launay, Amandine Gagneux-Brunon, Florelle Bellet and Marie-Noëlle BeyensTherapies 80 (5) 536 (2025)
https://doi.org/10.1016/j.therap.2024.12.012
Cannabinoids and Adverse Convulsive Effects: A Pharmacovigilance and Addictovigilance Analysis of Cases Reported in France
Marie‐Laure Laroche, Marion Labetoulle, Emilie Jouanjus, Edeltraut Kröger and Arsène ZongoFundamental & Clinical Pharmacology 39 (4) (2025)
https://doi.org/10.1111/fcp.70028
Unexpected haloperidol-induced yawning while neuroleptic switch, paradoxical reaction or dopaminergic supersensitivity? A case report
Jacques Hamard, François Montastruc, Dalil Boulefaa, Julie Haybrard and Julien LiTherapies 80 (5) 611 (2025)
https://doi.org/10.1016/j.therap.2025.02.014
Effets indésirables de l’association tezacaftor/ivacaftor/elexacaftor pouvant mener à un arrêt de traitement : à propos d’une série de 10 cas
Elora Blaisonneau, Brendan Le Daré, Marion Mercerolle, Astrid Bacle, Louise Triquet, Marie-Noëlle Osmont, Chantal Belleguic and Elisabeth PolardTherapies 80 (3) 279 (2025)
https://doi.org/10.1016/j.therap.2024.06.005
Rapid desensitization to insulin in a patient with diabetic ketoacidosis and insulin allergy
Emna Chtourou, Fatma Charfi, Imen Chabchoub, Hanen Ghozzi, Ahmed Hakim, Kammoun Thouraya, Khaled Zeghal and Lobna Ben MahmoudTherapies 80 (5) 616 (2025)
https://doi.org/10.1016/j.therap.2025.03.004
Fluconazole-induced Stevens-Johnson syndrome at Libreville University Hospital - Gabon: A case report
Pierre Constant Ntoutoume Nzoghe, Rim Lakhmiri, Sophie Coniquet, Landry Missounga, Solange Ntsame, Yahia Cherrah and Samira SerraguiInternational Journal of Risk & Safety in Medicine 36 (3) 134 (2025)
https://doi.org/10.1177/09246479251325475
Cefepime Concentration-Toxicity Relationship in Hematological Patients Treated With Continuous Infusion: A Prospective Study
Sébastien Lalanne, Marie-Noëlle Osmont, Louise Triquet, Jeff Morcet, Tony Marchand, Roch Houot, Elisabeth Polard, Marie-Clémence Verdier and Florian LemaitreClinical Infectious Diseases 81 (4) 721 (2025)
https://doi.org/10.1093/cid/ciaf205
Case report d’une intoxication volontaire mortelle avec de la mirtazapine et de la venlafaxine compliquée d’un pharmacobézoar massif
Romain Batton, Fabien Lamoureux, Marion Beuzelin, Jean-Philippe Rigaud and Antoine MarchalotTherapies (2025)
https://doi.org/10.1016/j.therap.2025.06.005
Nicolau syndrome: An avoidable iatrogenic complication leading to disabilities
Siméon YOBO-BI Manan, Sita N'ZOUÉ Kanga, TOURÉ Massiré, Célestin BÉNIÉ Adoubs, Yves-Cédric KEE Mankoh, Ahua Jean BERTRAND Kpangni, Claude Stéphane Batoué TIA Alain and KAMAGATE MamadouAfrican Journal of Pharmacy and Pharmacology 18 (6) 103 (2024)
https://doi.org/10.5897/AJPP2024.5389
Causality, Severity, Preventability and Predictability Assessments Scales for Adverse Drug Reactions: A Review
Pramod K Manjhi, Madhusudan P Singh and Mukesh KumarCureus (2024)
https://doi.org/10.7759/cureus.59975
An artificial intelligence algorithm for co‐clustering to help in pharmacovigilance before and during the COVID‐19 pandemic
Alexandre Destere, Giulia Marchello, Diane Merino, Nouha Ben Othman, Alexandre O. Gérard, Thibaud Lavrut, Delphine Viard, Fanny Rocher, Marco Corneli, Charles Bouveyron and Milou‐Daniel DriciBritish Journal of Clinical Pharmacology 90 (5) 1258 (2024)
https://doi.org/10.1111/bcp.16012
Sudden Sensorineural Hearing Loss after COVID-19 Vaccination: A Review of the Available Evidence through the Prism of Causality Assessment
Hung Thai-Van, Haleh Bagheri and Marie-Blanche Valnet-RabierVaccines 12 (2) 181 (2024)
https://doi.org/10.3390/vaccines12020181
Medication-overuse headache: A pharmacovigilance study in France
Mohamad Houssam Al Balkhi, Julien Moragny, Solène M. Laville, Sophie Liabeuf, Pauline-Eva Pecquet, Benjamin Batteux, Cosette Le Souder, Florelle Bellet, Valérie Gras and Kamel MasmoudiTherapies 79 (5) 565 (2024)
https://doi.org/10.1016/j.therap.2024.02.001
Évaluation de l’imputabilité médicamenteuse devant une suspicion de toxidermie
G. Gourier, S. Ingen-Housz-Oro, P. Sanchez-Pena and B. Lebrun-VignesAnnales de Dermatologie et de Vénéréologie - FMC 3 (6) 399 (2023)
https://doi.org/10.1016/j.fander.2023.02.011
Adverse cutaneous reactions to psychotropic drugs
A. El Kissouni, F. Hali, S. Chiheb, A. Meftah and H. FilaliRevue Française d'Allergologie 63 (5) 103668 (2023)
https://doi.org/10.1016/j.reval.2023.103668
Misdiagnosis of Tracher-Collins Syndrome Initially Attributed to Drug Teratogenicity: A Moroccan Case Report
A Lamzouri, A EL Rherbi, I Ratbi, FZ Laarabi, R Chahboune, SC Elalaoui, H Hamdaoui, RS Bencheikh and A SefianiBalkan Journal of Medical Genetics 26 (2) 69 (2023)
https://doi.org/10.2478/bjmg-2023-0018
Trends in adverse drug reactions related to oral weak opioid analgesics in therapeutic use in adults: A 10‐year French vigilances retrospective study
Weniko Caré, Sylvine Pinel, Laurène Dufayet, Jérôme Langrand, Joëlle Micallef and Dominique VodovarFundamental & Clinical Pharmacology 37 (6) 1205 (2023)
https://doi.org/10.1111/fcp.12929
Reality of drug-induced erythema multiforme: A French pharmacovigilance study
Sarah Demouche, Thomas Bettuzzi, Emilie Sbidian, Delphine Laugier Castellan, Marie-Noelle Osmont, Saskia Ingen-Housz-Oro and Bénédicte Lebrun-VignesTherapies 78 (6) 711 (2023)
https://doi.org/10.1016/j.therap.2023.03.004
From pharmacovigilance to pharmaceutical care: About a case of urticaria and angioedema
S. Mansour, FZN. Mekaouche, A. Amrani, FZ. Charif, F. Haouatti, H. Betaouaf, I. Senhadji, N. Bouchiba and H. ToumiRevue Française d'Allergologie 63 (7) 103712 (2023)
https://doi.org/10.1016/j.reval.2023.103712
Utilisation du dronabinol dans le traitement des douleurs neuropathiques réfractaires : retour d’expérience des patients suivis dans un Centre d’évaluation et de traitement de la douleur
E. Richet, L. Ferret, L. Gaboriau, P. Charpentier, L. Dujardin, J. Fulcrand and A. BoursierAnnales Pharmaceutiques Françaises 81 (4) 720 (2023)
https://doi.org/10.1016/j.pharma.2022.12.005
Amiodarone induced lung disease
Cristina Elena Mitrofan, Aurelia Cretu and Costel MitrofanArchive of Clinical Cases 9 (3) 126 (2022)
https://doi.org/10.22551/2022.36.0903.10217
Pulmonary hemorrhage in a neonate born to a woman with cystic fibrosis treated with targeted cystic fibrosis transmembrane conductance regulator modulator elexacaftor–tezacaftor–ivacaftor during pregnancy
Alexandra Nuytten, Anne Prevotat, Olivier Le Rouzic, Joëlle Dekemp, Sixtine Gilliot, Sophie Gautier, Kévin Le Duc and Charles GarabedianTherapies 77 (6) 743 (2022)
https://doi.org/10.1016/j.therap.2022.01.020
Baclofen-induced psoriasis
N. Sigg, J. Delaunay, C. Potey and G. DrablierAnnales de Dermatologie et de Vénéréologie 149 (4) 291 (2022)
https://doi.org/10.1016/j.annder.2022.03.009
Revue de la littérature sur la pharmacovigilance des médicaments issus des pharmacopées traditionnelles. Partie II : évaluation et prévention des risques
K. Ouoba, H. Lehmann, J.-Y. Pabst and R. SemdeAnnales Pharmaceutiques Françaises 80 (5) 635 (2022)
https://doi.org/10.1016/j.pharma.2021.11.007
Reversible anti-TNFα treatment induced dementia: A case report
Camille Hou, Emmanuel Azzi, Anne Salmon, Marie-Noëlle Osmont and Aleth PerdrigerJoint Bone Spine 88 (1) 105044 (2021)
https://doi.org/10.1016/j.jbspin.2020.06.017
Impact of a medico-pharmaceutical follow-up and an optimized communication between hospital and community on the readmission to the emergency department for an adverse drug event: URGEIM, study protocol for a randomized controlled trial
Cyril Breuker, Marie Faucanié, Marion Laureau, Damien Perier, Véronique Pinzani, Grégory Marin, Mustapha Sebbane and M. VillietTrials 22 (1) (2021)
https://doi.org/10.1186/s13063-021-05501-4
Childhood epidermal necrolysis and erythema multiforme major: a multicentre French cohort study of 62 patients
L. Giraud‐Kerleroux, N. Bellon, A. Welfringer‐Morin, S. Leclerc‐Mercier, I. Costedoat, J. Coquin, A. Brun, A.‐M. Roguedas‐Contios, C. Bernier, B. Milpied, F. Tétart, A. Du Thanh, N. Cordel, B. Bensaid, C. Fargeas, M. Tauber, S. Renolleau, F. Boralevi, S. Ingen‐Housz‐Oro and C. BodemerJournal of the European Academy of Dermatology and Venereology 35 (10) 2051 (2021)
https://doi.org/10.1111/jdv.17469
Hospital databases for the identification of adverse drug reactions: A 2‐year multicentre study in 9 French general hospitals
Marie‐Noëlle Osmont, Adeline Degremont, Hélène Jantzem, Youna Audouard‐Marzin, Sébastien Lalanne, Dominique Carlhant‐Kowalski, Eric Bellissant, Emmanuel Oger and Elisabeth PolardBritish Journal of Clinical Pharmacology 87 (2) 471 (2021)
https://doi.org/10.1111/bcp.14405
Hemangiol in infantile haemangioma: A paediatric post‐marketing surveillance drug study
Floriane Socchi, Michele Bigorre, Marion Normandin, Guillaume Captier, Didier Bessis, Michel Mondain, Catherine Blanchet, Mohamed Akkari, Pascal Amedro and Arthur GavottoBritish Journal of Clinical Pharmacology 87 (4) 1970 (2021)
https://doi.org/10.1111/bcp.14593
Interaction tamoxifène – clou de girofle : à propos d’un cas d’effet indésirable
S. Abou, J.-M. Ouedraogo, B. Hafsa, M.J. Belahcen and Y. RahaliLe Pharmacien Hospitalier et Clinicien 56 (2) 185 (2021)
https://doi.org/10.1016/j.phclin.2020.11.005
Démence réversible à l’arrêt d’un traitement par anti-TNFα
Camille Hou, Emmanuel Azzi, Anne Salmon, Marie-Noëlle Osmont and Aleth PerdrigerRevue du Rhumatisme 87 (6) 486 (2020)
https://doi.org/10.1016/j.rhum.2020.09.012
Severe Attack of Henoch-Schönlein Purpura With Neurological Involvement During Adalimumab Treatment for Crohn’s Disease
Manuelle Viguier, Guillaume Cadiot, Jean-Hugues Salmon, et al.Journal of Crohn's and Colitis 14 (4) 538 (2020)
https://doi.org/10.1093/ecco-jcc/jjz164
Allopurinol-Induced Oral Lichenoid Drug Reaction with Complete Regression after Drug Withdrawal
Alexandre Perez, Benjamin Lazzarotto, Jean-Pierre Carrel and Tommaso LombardiDermatopathology 7 (2) 18 (2020)
https://doi.org/10.3390/dermatopathology7020004
Allopurinol-Induced Oral Lichenoid Drug Reaction with Complete Regression after Drug Withdrawal
Alexandre Perez, Benjamin Lazzarotto, Jean-Pierre Carrel and Tommaso LombardiDermatopathology 7 (1) 18 (2020)
https://doi.org/10.3390/dermatopathology7010004
Comparative study of hypoglycaemia induced by opioids. Is it a class effect?
Basile Chrétien, Charles Dolladille, Léa Hamel-Sénécal, et al.Expert Opinion on Drug Safety 18 (10) 987 (2019)
https://doi.org/10.1080/14740338.2019.1646246
Adverse reactions related to brentuximab vedotin use: A real-life retrospective study
Béatrice Clarivet, Laure Vincent, Laurence Vergely, Virginie Bres, Kathleen Foglia, Guillaume Cartron, Dominique Hillaire-Buys and Jean-Luc FaillieTherapies 74 (3) 343 (2019)
https://doi.org/10.1016/j.therap.2018.07.004
Transient major hypothermia associated with acetaminophen: A pediatric case report and literature review
M.-S. Agier, N. Chollet, E. Bediou, M. Boyer Gervoise and A.-P. Jonville-BeraArchives de Pédiatrie 26 (6) 358 (2019)
https://doi.org/10.1016/j.arcped.2019.06.005
Vascularites médicamenteuses : à propos d’une série de 13 cas
Neila Fathallah, Bouraoui Ouni, Sana Mokni, et al.Therapies 74 (3) 347 (2019)
https://doi.org/10.1016/j.therap.2018.07.005
Gliptin Accountability in Mucous Membrane Pemphigoid Induction in 24 Out of 313 Patients
Olivier Gaudin, Vannina Seta, Marina Alexandre, et al.Frontiers in Immunology 9 (2018)
https://doi.org/10.3389/fimmu.2018.01030
Étude de la néphrotoxicité induite par les plantes chez les patients du service de néphrologie
N. Touiti, I. Iken, M. Chebaibi, S. Achour and T. Sqalli HoussainiToxicologie Analytique et Clinique 30 (2) S63 (2018)
https://doi.org/10.1016/j.toxac.2018.04.084
A case report of rare palmoplantar keratosis and nail dystrophy with imatinib
M. Benabbes, Z. Tazi Mezalek and B. MeddahAnnales Pharmaceutiques Françaises 75 (3) 172 (2017)
https://doi.org/10.1016/j.pharma.2016.12.006
Toxicodynetics in nordiazepam and oxazepam overdoses
L. Sacre, S.M. Ali, A. Villa, R. Jouffroy, J.-H. Raphalen, R. Garnier and F.J. BaudAnnales Pharmaceutiques Françaises 75 (3) 163 (2017)
https://doi.org/10.1016/j.pharma.2017.01.002
Syndrome de Lyell aux anti-PD1 d’évolution fatale
S. Demirtas, L. El Aridi, M. Acquitter, C. Fleuret and P. PlantinAnnales de Dermatologie et de Vénéréologie 144 (1) 65 (2017)
https://doi.org/10.1016/j.annder.2016.11.012
Imputabilité en pharmacovigilance : de la méthode française originelle aux méthodes réactualisées
Ghada Miremont-Salamé, Hélène Théophile, Françoise Haramburu and Bernard BégaudTherapies 71 (2) 171 (2016)
https://doi.org/10.1016/j.therap.2016.02.009
Toxicodynetics: A new discipline in clinical toxicology
F.J. Baud, P. Houzé, A. Villa, S.W. Borron and P. CarliAnnales Pharmaceutiques Françaises 74 (3) 173 (2016)
https://doi.org/10.1016/j.pharma.2016.02.003
Causality assessment in pharmacovigilance: The French method and its successive updates
Ghada Miremont-Salamé, Hélène Théophile, Françoise Haramburu and Bernard BégaudTherapies 71 (2) 179 (2016)
https://doi.org/10.1016/j.therap.2016.02.010
High-Dose Verapamil in Episodic and Chronic Cluster Headaches and Cardiac Adverse Events: Is It as Safe as We Think?
Joachim Alexandre, Xavier Humbert, Marion Sassier, et al.Drug Safety - Case Reports 2 (1) (2015)
https://doi.org/10.1007/s40800-015-0015-3
Iatrogénie médicamenteuse : contribution à l’uniformisation de la terminologie en langue française pour la pratique de soins et la recherche clinique
Lucien Roulet, Françoise Ballereau, Maryse Lapeyre-Mestre, Muriel Joris-Frasseren and Nathalie AsserayThérapie 70 (3) 283 (2015)
https://doi.org/10.2515/therapie/2014215
Adverse Drug Reactions in Pediatric Emergency Medicine
Domitille Darnis, Julien Mahé, Bénédicte Vrignaud, Christèle Gras-Le Guen, Gwenaelle Veyrac and Pascale JollietAnnals of Pharmacotherapy 49 (12) 1298 (2015)
https://doi.org/10.1177/1060028015602904
Cardiac Arrests Associated with Low Plasma and Tissue Levels of Local Anaesthetics
Joachim Alexandre, Xavier Humbert, Marion Sassier, et al.Thérapie (2015)
https://doi.org/10.2515/therapie/2015056
Chocs anaphylactiques peranesthésiques : contribution d'un entrepôt de données cliniques
Marie-Noëlle Osmont, Boris Campillo-Gimenez, Lucie Metayer, et al.Thérapie (2015)
https://doi.org/10.2515/therapie/2015055
Risk Assessment of Dimethylfumarate Residues in Dwellings Following Contamination by Treated Furniture
C. Rousselle, V. Pernelet‐Joly, C. Mourton‐Gilles, J. P. Lepoittevin, R. Vincent, A. Lefranc and R. GarnierRisk Analysis 34 (5) 879 (2014)
https://doi.org/10.1111/risa.12147
Facial Hyperpigmentation during Imatinib Therapy for Gastrointestinal Stromal Tumor
Imene Hamza, Emna Gaies, Sarrah Kastalli, Riadh Daghfous and Sihem El AidliTherapies 69 (3) 245 (2014)
https://doi.org/10.2515/therapie/2014018
Linear immunoglobulin A disease and vancomycin: letter in reply
S. Ingen-Housz-Oro, L. Valeyrie-Allanore, J. Chanal, O. Chosidow and P. WolkensteinBritish Journal of Dermatology 171 (6) 1602 (2014)
https://doi.org/10.1111/bjd.13174
Acute Hepatitis and Renal Failure Related to Intranasal Buprenorphine Misuse
Céline Eiden, Marie-Pierre Ripault, Dominique Larrey, Jean-Luc Faillie, Véronique Pinzani, Georges-Philippe Pageaux and Hélène PeyrièreAnnals of Pharmacotherapy 47 (12) 1721 (2013)
https://doi.org/10.1177/1060028013507429
Pneumopathies médicamenteuses en réanimation
J. Mankikian, A. -P. Jonville-Bera, P. Diot, et al.Réanimation 22 (1) 62 (2013)
https://doi.org/10.1007/s13546-012-0645-8
Toxidermie pityriasis rosé de Gibert-like induite par la pristinamycine
Sana Mokni, Hichem Belhadjali, Jihane Alkhalifa, et al.Therapies 68 (5) 326 (2013)
https://doi.org/10.2515/therapie/2013046
Linear IgA bullous dermatosis: comparison between the drug-induced and spontaneous forms
J. Chanal, S. Ingen-Housz-Oro, N. Ortonne, et al.British Journal of Dermatology 169 (5) 1041 (2013)
https://doi.org/10.1111/bjd.12488